Psychiatric symptoms of noradrenergic dysfunction: a pathophysiological view (Q38174210)

30 August 2017

Psychiatric symptoms of noradrenergic dysfunction: a pathophysiological view (English)

1 reference

30 August 2017

1 reference

Ken-ichi Yamamoto

1

1 reference

PubMed ID

24372896

30 August 2017

Toshikazu Shinba

series ordinal

2

1 reference

PubMed ID

24372896

30 August 2017

Mitsunobu Yoshii

series ordinal

3

1 reference

30 August 2017

29 December 2013

1 reference

Psychiatry and Clinical Neurosciences

30 August 2017

1 reference

30 August 2017

68

1 reference

30 August 2017

1

1 reference

30 August 2017

1-20

1 reference

A Specific Sympathomimetic Ergone in Adrenergic Nerve Fibres (Sympathin) and its Relations to Adrenaline and Nor-Adrenaline

30 August 2017

1 reference

A Syndrome produced by Diverse Nocuous Agents

21 January 2018

1 reference

The concentration of sympathin in different parts of the central nervous system under normal conditions and after the administration of drugs

21 January 2018

1 reference

Central Catecholamine Neuron Systems: Anatomy and Physiology of the Norepinephrine and Epinephrine Systems

21 January 2018

1 reference

Descending noradrenergic pathways involved in the A5 depressor response.

21 January 2018

1 reference

Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus

21 January 2018

1 reference

Medullary neurones regulate hypothalamic corticotropin-releasing factor cell responses to an emotional stressor

21 January 2018

1 reference

Brain circuits involved in corticotropin-releasing factor-norepinephrine interactions during stress

21 January 2018

1 reference

Locus coeruleus neurons and sympathetic nerves: activation by cutaneous sensory afferents.

21 January 2018

1 reference

Correlational analysis of central noradrenergic neuronal activity and sympathetic tone in behaving cats

21 January 2018

1 reference

Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups.

21 January 2018

1 reference

Impulse activity of locus coeruleus neurons in awake rats and monkeys is a function of sensory stimulation and arousal

21 January 2018

1 reference

Microinfusion of clonidine and yohimbine into locus coeruleus alters EEG power spectrum: effects of aging and reversal by phosphatidylserine

21 January 2018

1 reference

Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies

21 January 2018

1 reference

Noradrenaline systems in the hypothalamus, amygdala and locus coeruleus are involved in the provocation of anxiety: basic studies

21 January 2018

1 reference

Direct evidence of conditioned fear-elicited enhancement of noradrenaline release in the rat hypothalamus assessed by intracranial microdialysis.

21 January 2018

1 reference

Noradrenergic function in generalized anxiety disorder: effects of yohimbine in healthy subjects and patients with generalized anxiety disorder

21 January 2018

1 reference

Anxiogenic properties of yohimbine. I. Behavioral, physiological and biochemical measures.

21 January 2018

1 reference

Yohimbine's anxiogenic action: evidence for noradrenergic and dopaminergic sites

21 January 2018

1 reference

Anxiogenic properties of cocaine in the rat evaluated with the elevated plus-maze

21 January 2018

1 reference

Norepinephrine signaling through beta-adrenergic receptors is critical for expression of cocaine-induced anxiety

21 January 2018

1 reference

Involvement of norepinephrine in startle arousal after acute and chronic d-amphetamine administration

21 January 2018

1 reference

Noradrenergic agonists and antagonists: Effects on conditioned fear as measured by the potentiated startle paradigm

21 January 2018

1 reference

Fear-potentiated startle: a neural and pharmacological analysis

21 January 2018

1 reference

Effects of lesioning noradrenergic neurones in the locus coeruleus on conditioned and unconditioned aversive behaviour in the rat.

21 January 2018

1 reference

Neurobiology of fear responses: the role of the amygdala

21 January 2018

1 reference

Clonidine injections into the lateral nucleus of the amygdala block acquisition and expression of fear-potentiated startle

21 January 2018

1 reference

Effects of clonidine injections into the bed nucleus of the stria terminalis on fear and anxiety behavior in rats

21 January 2018

1 reference

Comparison of behavioral changes in cats treated with intracerebroventricular 6-hydroxydopamine and reserpine

21 January 2018

1 reference

Effects of 6-hydroxydopamine on shock-elicited aggression, emotionality and maternal behavior in female rats

21 January 2018

1 reference

Shock-induced aggression: effects of 6-hydroxydopamine and other pharmacological agents.

21 January 2018

1 reference

6-Hydroxydopa Depletion of Brain Norepinephrine and the Facilitation of Aggressive Behavior

21 January 2018

1 reference

A modern neurobiological concept of vigilance.

21 January 2018

1 reference

Functional influence of the central noradrenergic system on the skin conductance activity in rats.

21 January 2018

1 reference

Skin conductance response after 6-hydroxydopamine lesion of central noradrenaline system in cats

21 January 2018

1 reference

Habituation failure of skin conductance response after intraventricular administration of 6-hydroxydopamine in cats.

21 January 2018

1 reference

Skin conductance activity after intraventricular administration of 6-hydroxydopa in rats.

21 January 2018

1 reference

Effects of locus coeruleus inactivation on electroencephalographic activity in neocortex and hippocampus

21 January 2018

1 reference

Auditory-evoked response of the cortex after yohimbine administration: phase advance effect of central noradrenergic activation

21 January 2018

1 reference

Alpha2-noradrenergic effects on ERP and behavioral indices of auditory information processing

21 January 2018

1 reference

Decision making, the P3, and the locus coeruleus-norepinephrine system

21 January 2018

1 reference

Effects of systemic clonidine on auditory event-related potentials in squirrel monkeys

21 January 2018

1 reference

The effect of D-amphetamine, clonidine, and yohimbine on human information processing

21 January 2018

1 reference

Electrophysiological and neuropsychological effects of a central alpha 2-antagonist atipamezole in healthy volunteers.

21 January 2018

1 reference

Locus coeruleus activity in monkey: phasic and tonic changes are associated with altered vigilance.

21 January 2018

1 reference

Psychophysiologic assessment of posttraumatic stress disorder imagery in Vietnam combat veterans

21 January 2018

1 reference

Physiologic responses to loud tones in Israeli patients with posttraumatic stress disorder.

21 January 2018

1 reference

Meta-analytic review of event-related potential studies in post-traumatic stress disorder

21 January 2018

1 reference

CSF Norepinephrine Concentrations in Posttraumatic Stress Disorder

21 January 2018

1 reference

Propranolol treatment for childhood posttraumatic stress disorder, acute type. A pilot study.

21 January 2018

1 reference

Pharmacologic reduction of CNS noradrenergic activity in PTSD: the case for clonidine and prazosin

21 January 2018

1 reference

Prazosin treatment of trauma nightmares and sleep disturbance in soldiers deployed in Iraq

21 January 2018

1 reference

Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder

21 January 2018

1 reference

Noradrenergic mechanisms in the pathophysiology of post-traumatic stress disorder.

21 January 2018

1 reference

Electrodermal activity in anxiety disorders.

21 January 2018

1 reference

Physiological, biochemical and subjective parameters in anxiety patients with panic disorder during stress exposure as compared with healthy controls.

21 January 2018

1 reference

Autonomic instability during relaxation in panic disorder.

21 January 2018

1 reference

Cognitive functions and the state of nonspecific brain systems in panic disorders.

21 January 2018

1 reference

Dose-response relationship for oral idazoxan effects in healthy human subjects: comparison with oral yohimbine

21 January 2018

1 reference

Noradrenergic function in generalized anxiety disorder, major depressive disorder, and healthy subjects.

21 January 2018

1 reference

Skin conductance reaction (SCR)-habituation test, a tool to detect anxiolytic activity. Its justification by the correlation between SCR-habituation test activities and specific binding potencies in benzodiazepines.

21 January 2018

1 reference

Effects of Clonidine on Anxiety Disorders

21 January 2018

1 reference

Beta-blockers in anxiety disorders

21 January 2018

1 reference

The role of central noradrenergic dysregulation in anxiety disorders: evidence from clinical studies

21 January 2018

1 reference

Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.

21 January 2018

1 reference

Physiological measures in agitated and retarded depressed patients

21 January 2018

1 reference

Cerebrospinal fluid amine metabolites. Relationships with behavioral measurements in depressed, manic, and healthy control subjects.

21 January 2018

1 reference

Desipramine-yohimbine combination treatment of refractory depression. Implications for the beta-adrenergic receptor hypothesis of antidepressant action

21 January 2018

1 reference

CSF monoamine metabolites in mania

21 January 2018

1 reference

Dysphoric mania. Clinical and biological correlates.

21 January 2018

1 reference

Molecular pathology of schizophrenia: more than one disease process?

21 January 2018

1 reference

The dopamine hypothesis: an overview of studies with schizophrenic patients

21 January 2018

1 reference

Insomnia as a predictor for symptom worsening following antipsychotic withdrawal in schizophrenia.

21 January 2018

1 reference

Evidence of High and Low Levels of Physiological Arousal in Schizophrenics

21 January 2018

1 reference

EEG-brain mapping in schizophrenics with predominantly positive and negative symptoms. Comparative studies with remoxipride/haloperidol.

21 January 2018

1 reference

Left auditory cortex gamma synchronization and auditory hallucination symptoms in schizophrenia

21 January 2018

1 reference

Quantitative EEG and low resolution electromagnetic tomography (LORETA) imaging of patients with persistent auditory hallucinations.

21 January 2018

1 reference

Visual evoked potential correlates of positive/negative symptoms in schizophrenia

21 January 2018

1 reference

Specific P300 features in patients with cycloid psychosis.

21 January 2018

1 reference

Possible noradrenergic dysfunction in schizophrenia

21 January 2018

1 reference

Antidepressants in 'depressed' schizophrenic inpatients. A controlled trial.

21 January 2018

1 reference

Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia.

21 January 2018

1 reference

Provocation of Schizophrenic Symptoms by Intravenous Administration of Methylphenidate

21 January 2018

1 reference

Schizophrenic Symptoms Improve with Apomorphine

21 January 2018

1 reference

Time course of D2-dopamine receptor occupancy examined by PET after single oral doses of haloperidol

21 January 2018

1 reference

The therapeutic latency of neuroleptic drugs and nonspecific postjunctional supersensitivity

21 January 2018

1 reference

Chronic haloperidol inactivates brain noradrenergic neurons.

21 January 2018

1 reference

Schizophrenia: elevated cerebrospinal fluid norepinephrine

21 January 2018

1 reference

CSF norepinephrine in schizophrenia is elevated prior to relapse after haloperidol withdrawal

21 January 2018

1 reference

Cerebrospinal Fluid Amine Metabolites in Acute Schizophrenia

21 January 2018

1 reference

Cerebroventricular size and cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy volunteers

21 January 2018

1 reference

CSF Dopamine β-Hydroxylase in Schizophrenia

21 January 2018

1 reference

Norepinephrine in Chronic Paranoid Schizophrenia: Above-Normal Levels in Limbic Forebrain

21 January 2018

1 reference

Brain catecholamines in schizophrenia -- a good case for noradrenaline.

21 January 2018

1 reference

Possible increase of dopamine-beta-hydroxylase activity in the locus ceruleus of paranoid schizophrenic patients: a preliminary post-mortem study

21 January 2018

1 reference

Dopamine-β-Hydroxylase Deficits in the Brains of Schizophrenic Patients

21 January 2018

1 reference

Increased volume of the pigmented neurons in the locus coeruleus of schizophrenic subjects: a stereological study.

21 January 2018

1 reference

Proposal for a noradrenaline hypothesis of schizophrenia

21 January 2018

1 reference

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

The disabilities of chronic schizophrenia--their nature and the factors contributing to their development.

21 January 2018

1 reference

Human sympathetic nerve biology: parallel influences of stress and epigenetics in essential hypertension and panic disorder

21 January 2018

1 reference

Delayed increase of brain noradrenaline after acute footshock stress in rats

21 January 2018

1 reference

Regional rat brain noradrenaline turnover in response to restraint stress.

21 January 2018

1 reference

Sensitization of norepinephrine activity following acute and chronic footshock.

21 January 2018

1 reference

The effect of acute, chronic and chronic intermittent stress on the central noradrenergic system.

21 January 2018

1 reference

The effects of footshock and handling on tyrosine hydroxylase activity in synaptosomes and solubilised preparations from rat brain

21 January 2018

1 reference

Footshock treatment activates catecholamine synthesis in slices of mouse brain regions

21 January 2018

1 reference

Temporal changes in tyrosine hydroxylase mRNA levels in A1, A2 and locus ceruleus neurons following electrical stimulation of A1 noradrenergic neurons

21 January 2018

1 reference

Differential effect of membrane depolarization on levels of tyrosine hydroxylase and dopamine beta-hydroxylase mRNAs in PC12 pheochromocytoma cells.

21 January 2018

1 reference

Heightened transcription for enzymes involved in norepinephrine biosynthesis in the rat locus coeruleus by immobilization stress.

21 January 2018

1 reference

Effect of novel stressors on gene expression of tyrosine hydroxylase and monoamine transporters in brainstem noradrenergic neurons of long-term repeatedly immobilized rats

21 January 2018

1 reference

The role of norepinephrine in differential response to stress in an animal model of posttraumatic stress disorder

21 January 2018

1 reference

Systemic naloxone administration potentiates locus coeruleus noradrenergic neuronal activity under stressful but not non-stressful conditions.

21 January 2018

1 reference

The beginning of the end for the Kraepelinian dichotomy.

21 January 2018

1 reference

The neuropharmacology of psychosis

21 January 2018

1 reference

Firing of 'possibly' cholinergic neurons in the rat laterodorsal tegmental nucleus during sleep and wakefulness

21 January 2018

1 reference

A cholinoceptive desynchronized sleep induction zone in the anterodorsal pontine tegmentum: locus of the sensitive region

21 January 2018

1 reference

Hypothalamo-preoptic histaminergic projections in sleep-wake control in the cat.

21 January 2018

1 reference

A microdialysis study of the noradrenergic response in rat frontal cortex and hypothalamus to a conditioned cue for aversive, naturalistic environmental stimuli.

21 January 2018

1 reference

Peripheral, autonomic regulation of locus coeruleus noradrenergic neurons in brain: putative implications for psychiatry and psychopharmacology

21 January 2018

1 reference

Decrease in heart rate variability response to task is related to anxiety and depressiveness in normal subjects.

21 January 2018

1 reference

Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholia

21 January 2018

1 reference

P300 amplitude is related to clinical state in severely and moderately ill patients with schizophrenia

21 January 2018

1 reference

Dopamine-beta-hydroxylase activity and homovanillic acid in spinal fluid of schizophrenics with brain atrophy

21 January 2018

1 reference

The Role of Norepinephrine in the Behavioral and Psychological Symptoms of Dementia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/PCN.12126

1 reference

30 August 2017

1 reference

PubMed ID

24372896